Es demasiado pronto para declarar al Covid endémico, dice el CEO de Novartis Narasimhan - Salud News
Novartis presentará nuevos datos de Hematología para pacientes con trastornos graves
Vas Narasimhan Ceo Swiss Pharmaceutical Group - Foto de stock de contenido editorial: imagen de stock | Shutterstock Editorial
Vasant Narasimhan appointed CEO of Novartis - Company news - pig333, pig to pork community
Novartis CEO sees 'better place' with Covid by year-end | Mint
The 'student' of leadership who seeks to inspire his employees | Financial Times
We need short-term launches to keep driving growth: Novartis CEO - BusinessToday
21 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Las farmacéuticas despliegan su estrategia de 'spin off' para dar valor | Industria
PHARMACOSERÍAS Marketing Farmacéutico/Pharmaceutical Marketing: NOVARTIS: Mi "amigo" Joe (Jimenez) no dijo todo...(III) y va preso. )
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Novartis aumenta sus beneficios un 9% en 2018
Vas Narasimhan – Chief Executive Officer – Novartis | LinkedIn
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AQ6AEJN4IJMKPDF4JS6QOCORLM.jpg "Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters")
Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Novartis fotografías e imágenes de alta resolución - Página 9 - Alamy
21 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Vasant Narasimhan Chief Executive Officer Novartis - Foto de stock de contenido editorial: imagen de stock | Shutterstock Editorial
21 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Vas Narasimhan anuncia el laboratorio de innovación de Inteligencia Artificial - YouTube
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis CEO Vas Narasimhan on the timeline for coronavirus treatments
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
